NCT06796101

Brief Summary

There are many studies in the literature on transcutaneous vagus nerve stimulation (VNS) and controlled breathing exercises (CBE), but there are limited studies examining the effects of both interventions on performance and the autonomic nervous system. The investigators aim to contribute to the literature by examining the effects of VNS and CBE on performance and the autonomic nervous system in moderately physically active individuals and their superiority over each other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

July 9, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2025

Completed
Last Updated

December 9, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

January 16, 2025

Last Update Submit

December 6, 2025

Conditions

Keywords

Transcutaneous vagus nerve stimulationPerformanceControlled breathing exercisesAutonomic nervous systemrecreactional

Outcome Measures

Primary Outcomes (2)

  • Performance

    Individuals will be taken to the treadmill and the distance and time taken until the maximum heart rate value reaches 80% will be recorded. The maximum heart rate value will be determined for each individual according to the formula 220-age. The participants will walk at a speed of 2 km/h for 1 minute, at a speed of 4 km/h for 1 minute and at a speed of 6 km/h, and the distance and time taken until the maximum heart rate reaches 80% will be recorded. In the termination phase of the run, a walk will be performed at a speed of 4 km/h for 1 minute and a speed of 2 km/h for 1 minute and will be completed.

    Baseline and 2 weeks.

  • Autonomic nervous system

    Heart rate change will be evaluated for the evaluation of the autonomic nervous system. Polar H9 heart rate sensor chest strap and wristwatch will be used to measure analytical heart rate change. During the assessment, the participant will be seated in a chair and the Polar system chest strap will be placed just above the sternum, and ultrasound gel will be used to increase the sensor's conductivity. This method is valid with an electrocardiogram. Heart rate variability parameters such as RMSSD, LF, and HF will be measured.

    Baseline and 2 weeks.

Secondary Outcomes (6)

  • International Physical Activity Questionnaire

    Baseline

  • Modified Borg Scale

    Baseline and 2 weeks.

  • Perceived Stress Scale

    Baseline and 2 weeks.

  • Blood Pressure Measurement

    Baseline and 2 weeks.

  • Pulse

    Baseline and 2 weeks.

  • +1 more secondary outcomes

Study Arms (2)

Transcutaneus vagus nerve stimulation

EXPERIMENTAL

This group will receive Transcutaneous vagus nerve stimulation from bilateral ear for two weeks, 10 sessions.

Device: Vagus Nerve Stimulation

Controlled breathing exercise group

EXPERIMENTAL

Controlled breathing exercises include thoracic expansion exercises, Nadi Shodhana Pranayama, Bhramari Pranayama, Kapalabhati and Physiological-sighing exercises.

Other: Controlled breathing exercises

Interventions

In the study, CE certified vagus nerve stimulation device Vagustim will be used. Transcutaneous auricular vagus nerve stimulation will be applied bilaterally. The stimulation pulse width is 300 microseconds, frequency is 10 Hz and will be applied biphasically for 20 minutes.

Transcutaneus vagus nerve stimulation

A controlled breathing exercise group will continue for a total of 2 weeks and will receive 10 sessions of 20 minutes per day. The thoracic expansion exercise will be performed in 10 repetitions. In each intervention session, 2 sets of nadi shodhana pranayama consisting of 8 respiratory cycles will be applied to the patients, with a 2-minute rest period between the sets. Kapalabhati will be practised for 3 minutes, with 15 quick breaths in 10 seconds followed by a 20-second break (a total of 30 breaths per minute). In each session, 2 sets of bhramari pranayama consisting of 10 breathing cycles will be performed at a low respiratory rate, with a 1-minute rest period between sets. The physiological sigh exercise involves the first inspiration phase being 1 second, the second phase 0.25 seconds, and the exhalation 2 seconds for 3 minutes.

Controlled breathing exercise group

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals with a moderate level of physical activity according to the International Physical Activity Scale
  • No orthopedic obstacle to exertion
  • Being male

You may not qualify if:

  • Having any active or chronic disease
  • Having cooperation problems
  • Using regular medication for any chronic condition within the last year
  • Being a smoker
  • Having had heart surgery
  • Having had surgery on the respiratory system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bahçesehir University

Istanbul, Istanbul, 34353, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Vagus Nerve Stimulation

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeutics

Study Officials

  • Okan ŞAHİN, PT, MSc

    Bahçeşehir University

    PRINCIPAL INVESTIGATOR
  • Ali Veysel ÖZDEN, MD, PHD

    Bahçeşehir University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Individuals who are moderately physically active according to the physical activity scale between the ages of 18-35 who met the inclusion criteria will be included in the study. The sample size of the study is calculated as 64 and randomized to vagus stimulation and controlled breathing exercise groups. All evaluations of the participants will be held at Bahçeşehir University Faculty of Health Sciences Biomechanics chiropractic laboratory.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, PT (Physiotherapist), MSc

Study Record Dates

First Submitted

January 16, 2025

First Posted

January 28, 2025

Study Start

July 9, 2025

Primary Completion

November 21, 2025

Study Completion

December 5, 2025

Last Updated

December 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations